US Stock MarketDetailed Quotes

ERNA Eterna Therapeutics

Watchlist
  • 0.250
  • +0.003+1.05%
Close Dec 20 16:00 ET
12.85MMarket Cap-0.03P/E (TTM)

Eterna Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-7.90%-6.29M
41.66%-2.26M
38.06%-3.75M
2.71%-20.41M
14.24%-4.66M
4.74%-5.83M
3.03%-3.87M
-11.36%-6.05M
10.69%-20.98M
20.45%-5.44M
Net income from continuing operations
-375.84%-26.6M
-22.65%-5.53M
-22.73%-6.65M
11.84%-21.67M
-37.07%-6.15M
23.59%-5.59M
-32.67%-4.51M
42.23%-5.42M
79.94%-24.58M
43.55%-4.49M
Operating gains losses
113,345.00%22.65M
28.42%-136K
51.11%68K
98.07%-203K
91.61%-38K
97.69%-20K
98.26%-190K
-97.34%45K
-212.45%-10.52M
---453K
Depreciation and amortization
-12.77%451K
817.46%578K
772.58%541K
125.96%1.12M
459.30%481K
327.27%517K
-58.55%63K
-55.07%62K
8.28%497K
-30.08%86K
Other non cash items
-42.42%95K
12.01%653K
1,917.65%1.03M
467.76%1.22M
165.72%416K
685.71%165K
96.96%583K
-90.38%51K
-99.75%214K
---633K
Change In working capital
-206.35%-3.28M
5,252.94%1.75M
166.22%980K
-157.06%-2.12M
236.44%468K
-173.91%-1.07M
-101.54%-34K
-470.93%-1.48M
261.94%3.71M
63.35%-343K
-Change in receivables
105.18%41K
136.50%123K
-75.66%74K
301.15%527K
5,508.00%1.35M
-241.38%-792K
-339.01%-337K
308.22%304K
60.24%-262K
96.23%-25K
-Change in prepaid assets
289.68%491K
87.81%-73K
-0.74%807K
-197.33%-556K
-330.93%-896K
-17.11%126K
41.56%-599K
172.82%813K
78.00%-187K
49.81%388K
-Change in payables and accrued expense
-150.49%-563K
-25.60%651K
101.09%24K
-193.15%-4.65M
-2,106.33%-4.43M
-54.93%1.12M
-51.63%875K
-553.50%-2.2M
1,128.87%4.99M
176.47%221K
-Change in other current assets
--0
100.27%1K
--0
256.97%1.01M
1,346.03%3.93M
-610.53%-2.43M
-578.18%-373K
-263.64%-108K
---646K
-1,116.13%-315K
-Change in other current liabilities
-592.51%-2.76M
174.25%1.1M
122.99%123K
621.08%964K
187.91%538K
193.03%561K
-70.04%400K
-75.41%-535K
37.71%-185K
-124.18%-612K
-Change in other working capital
-239.54%-487K
---47K
-119.20%-48K
--582K
---17K
--349K
--0
--250K
----
----
Cash from discontinued investing activities
Operating cash flow
-7.88%-6.29M
41.66%-2.26M
38.06%-3.75M
2.71%-20.41M
14.24%-4.66M
4.74%-5.83M
3.03%-3.87M
-11.36%-6.05M
10.69%-20.98M
20.45%-5.44M
Investing cash flow
Cash flow from continuing investing activities
-19K
-249K
-97K
59.57%-19K
-114.73%-19K
0
0
0
99.79%-47K
187.76%129K
Net PPE purchase and sale
---19K
---249K
---97K
59.57%-19K
-114.73%-19K
--0
--0
--0
69.48%-47K
187.76%129K
Cash from discontinued investing activities
Investing cash flow
---19K
---249K
---97K
59.57%-19K
-114.73%-19K
--0
--0
--0
99.79%-47K
187.76%129K
Financing cash flow
Cash flow from continuing financing activities
-54.48%3.89M
-107.05%-22K
1.39M
-15.44%16.56M
1.46%7.7M
142,233.33%8.54M
2,500.00%312K
0
-68.21%19.58M
1,912.17%7.59M
Net issuance payments of debt
-55.40%3.89M
--0
--1.41M
825,250.00%16.5M
778,900.00%7.79M
--8.72M
--0
--0
99.79%-2K
99.76%-1K
Net common stock issuance
--0
----
----
-98.38%320K
--0
--0
----
----
-68.48%19.71M
470.64%7.71M
Cash dividends paid
--0
----
----
0.00%-16K
0.00%-8K
--0
----
----
-100.00%-16K
0.00%-8K
Proceeds from stock option exercised by employees
----
----
----
--0
----
----
----
----
-30.00%7K
--0
Net other financing activities
--0
---14K
---20K
-116.38%-251K
31.53%-76K
----
----
----
---116K
---111K
Cash from discontinued financing activities
Financing cash flow
-54.48%3.89M
-107.05%-22K
--1.39M
-15.44%16.56M
1.46%7.7M
142,233.33%8.54M
2,500.00%312K
--0
-68.21%19.58M
1,912.17%7.59M
Net cash flow
Beginning cash position
12.63%6.68M
-2.96%9.21M
-24.91%11.67M
-8.50%15.54M
-34.77%8.65M
-69.43%5.93M
-59.61%9.49M
-8.50%15.54M
942.02%16.99M
-45.64%13.25M
Current changes in cash
-189.06%-2.42M
28.93%-2.53M
59.35%-2.46M
-168.07%-3.87M
32.23%3.02M
144.11%2.71M
13.02%-3.56M
-192.85%-6.05M
-109.40%-1.44M
130.91%2.29M
End cash Position
-50.68%4.26M
12.63%6.68M
-2.96%9.21M
-24.91%11.67M
-24.91%11.67M
-34.77%8.65M
-69.43%5.93M
-59.61%9.49M
-8.50%15.54M
-8.50%15.54M
Free cash flow
-8.20%-6.3M
35.23%-2.51M
36.39%-3.85M
3.98%-20.43M
14.22%-4.68M
5.41%-5.83M
7.37%-3.87M
-10.42%-6.05M
10.02%-21.27M
21.82%-5.46M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -7.90%-6.29M41.66%-2.26M38.06%-3.75M2.71%-20.41M14.24%-4.66M4.74%-5.83M3.03%-3.87M-11.36%-6.05M10.69%-20.98M20.45%-5.44M
Net income from continuing operations -375.84%-26.6M-22.65%-5.53M-22.73%-6.65M11.84%-21.67M-37.07%-6.15M23.59%-5.59M-32.67%-4.51M42.23%-5.42M79.94%-24.58M43.55%-4.49M
Operating gains losses 113,345.00%22.65M28.42%-136K51.11%68K98.07%-203K91.61%-38K97.69%-20K98.26%-190K-97.34%45K-212.45%-10.52M---453K
Depreciation and amortization -12.77%451K817.46%578K772.58%541K125.96%1.12M459.30%481K327.27%517K-58.55%63K-55.07%62K8.28%497K-30.08%86K
Other non cash items -42.42%95K12.01%653K1,917.65%1.03M467.76%1.22M165.72%416K685.71%165K96.96%583K-90.38%51K-99.75%214K---633K
Change In working capital -206.35%-3.28M5,252.94%1.75M166.22%980K-157.06%-2.12M236.44%468K-173.91%-1.07M-101.54%-34K-470.93%-1.48M261.94%3.71M63.35%-343K
-Change in receivables 105.18%41K136.50%123K-75.66%74K301.15%527K5,508.00%1.35M-241.38%-792K-339.01%-337K308.22%304K60.24%-262K96.23%-25K
-Change in prepaid assets 289.68%491K87.81%-73K-0.74%807K-197.33%-556K-330.93%-896K-17.11%126K41.56%-599K172.82%813K78.00%-187K49.81%388K
-Change in payables and accrued expense -150.49%-563K-25.60%651K101.09%24K-193.15%-4.65M-2,106.33%-4.43M-54.93%1.12M-51.63%875K-553.50%-2.2M1,128.87%4.99M176.47%221K
-Change in other current assets --0100.27%1K--0256.97%1.01M1,346.03%3.93M-610.53%-2.43M-578.18%-373K-263.64%-108K---646K-1,116.13%-315K
-Change in other current liabilities -592.51%-2.76M174.25%1.1M122.99%123K621.08%964K187.91%538K193.03%561K-70.04%400K-75.41%-535K37.71%-185K-124.18%-612K
-Change in other working capital -239.54%-487K---47K-119.20%-48K--582K---17K--349K--0--250K--------
Cash from discontinued investing activities
Operating cash flow -7.88%-6.29M41.66%-2.26M38.06%-3.75M2.71%-20.41M14.24%-4.66M4.74%-5.83M3.03%-3.87M-11.36%-6.05M10.69%-20.98M20.45%-5.44M
Investing cash flow
Cash flow from continuing investing activities -19K-249K-97K59.57%-19K-114.73%-19K00099.79%-47K187.76%129K
Net PPE purchase and sale ---19K---249K---97K59.57%-19K-114.73%-19K--0--0--069.48%-47K187.76%129K
Cash from discontinued investing activities
Investing cash flow ---19K---249K---97K59.57%-19K-114.73%-19K--0--0--099.79%-47K187.76%129K
Financing cash flow
Cash flow from continuing financing activities -54.48%3.89M-107.05%-22K1.39M-15.44%16.56M1.46%7.7M142,233.33%8.54M2,500.00%312K0-68.21%19.58M1,912.17%7.59M
Net issuance payments of debt -55.40%3.89M--0--1.41M825,250.00%16.5M778,900.00%7.79M--8.72M--0--099.79%-2K99.76%-1K
Net common stock issuance --0---------98.38%320K--0--0---------68.48%19.71M470.64%7.71M
Cash dividends paid --0--------0.00%-16K0.00%-8K--0---------100.00%-16K0.00%-8K
Proceeds from stock option exercised by employees --------------0-----------------30.00%7K--0
Net other financing activities --0---14K---20K-116.38%-251K31.53%-76K---------------116K---111K
Cash from discontinued financing activities
Financing cash flow -54.48%3.89M-107.05%-22K--1.39M-15.44%16.56M1.46%7.7M142,233.33%8.54M2,500.00%312K--0-68.21%19.58M1,912.17%7.59M
Net cash flow
Beginning cash position 12.63%6.68M-2.96%9.21M-24.91%11.67M-8.50%15.54M-34.77%8.65M-69.43%5.93M-59.61%9.49M-8.50%15.54M942.02%16.99M-45.64%13.25M
Current changes in cash -189.06%-2.42M28.93%-2.53M59.35%-2.46M-168.07%-3.87M32.23%3.02M144.11%2.71M13.02%-3.56M-192.85%-6.05M-109.40%-1.44M130.91%2.29M
End cash Position -50.68%4.26M12.63%6.68M-2.96%9.21M-24.91%11.67M-24.91%11.67M-34.77%8.65M-69.43%5.93M-59.61%9.49M-8.50%15.54M-8.50%15.54M
Free cash flow -8.20%-6.3M35.23%-2.51M36.39%-3.85M3.98%-20.43M14.22%-4.68M5.41%-5.83M7.37%-3.87M-10.42%-6.05M10.02%-21.27M21.82%-5.46M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.